Inspire Medical Systems sets terms for IPO
By HME News Staff
Updated Tue April 24, 2018
MINNEAPOLIS - Inspire Medical Systems plans to raise $75 million by offering 5 million shares at a price range of $14 to $16 as part of an initial public offering that it announced earlier this month. Insiders plan to purchase $15 million worth of shares in the IPO, according to Nasdaq. Inspire Medical Systems, which plans to list on the New York Stock Exchange under the symbol INSP, makes FDA-approved neurostimulation technology that provides treatment for moderate to severe obstructive sleep apnea. It generated $29 million in sales for the 12 months ended Dec. 31, 2017.
Comments